Skip to main content

Table 4 Multivariate analysis of STAT3 polymorphisms on survival

From: Genetic polymorphisms of STAT3 correlated with prognosis in diffuse large B-cell lymphoma patients treated with rituximab

Variable

Hazard ratio

95% CI

p

IPI score

2.792

1.407 - 5.544

0.003

STAT3 polymorphisms

2.787

1.346 - 5.773

0.006

B symptoms

0.420

0.210 - 0.839

0.014